FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF ELETRIPTAN FAST DISSOLVING ORAL FILMS
Abstract
The present study aimed at preparing fast dissolving oral films of Eletriptan as a model drug which is used for the migraine treatment. Fast dissolving dosage forms have acquired great importance in pharmaceutical industry because of their unique properties. In the present research work various trials were carried out using different grades of HPMC E3, E6, and E15, maltodextrin DE6 and other polymers by solvent casting method. The prepared films were evaluated for film thickness, folding endurance, surface pH, morphological properties, % drug content and content uniformity, tensile strength, percent elongation, in vitro disintegration time and in vitro dissolution studies. The optimized formulation F24 prepared using HPMC E15 showed minimum disintegration time (10 sec), highest dissolution rate i.e. 99% of drug within 8 min and satisfactory physicochemical properties. The optimized film was evaluated for its bioavailability compared with pure drug as reference standard. Statistical analysis revealed that no significant difference between the bioavailability parameters of the film and the reference standard indicated that they exhibited comparable plasma level-time profiles. These findings suggest that the fast dissolving film containing Eletriptan is considered to be potentially useful for the treatment of migraine where quick onset of action is desirable.
Keywords:
Eletriptan, fast dissolving films, solvent casting method, HPMCDOI
https://doi.org/10.25004/IJPSDR.2018.100604References
Chugh I, Seth N, Rana AC, Gupta S. Oral sustained release drug delivery system. International research journal of pharmacy. 2010; 3 (5): 57-62.
Siddiqui N, Garg G, Sharma PK. A Short Review on “A Novel Approach in Oral Fast Dissolving Drug Delivery System and Their Patents”. Advances in Biological Research. 2011; 5 (6): 291-303.
Patel AR, Prajapati DS, Raval JA. Fast Dissolving Films (FDFs) as a Newer Venture in Fast Dissolving Dosage Forms. International Journal of Drug Development & Research. 2010; 2(2): 232-246..
Nagaraju R, Sujatha B, Vidyadhara S, Sasidhar RLC. Design and evaluation of fast dissolving films containing Nizatidine. Indian journal of pharmaceutical education and research. 2012; 46(4): 318-322.
Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J. Investigative Dermatol. 1976; 67(6): 713-717.
Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006; 5: 148–57.
Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005; 11(8): S3-10.
Panchal MS, Patel H, Bagada A, Vadalia KR. Formulation and Evaluation of Mouth Dissolving Film of Ropinirole Hydrochloride by Using Pullulan Polymers. International Journal of Pharmaceutical Research & Allied Sciences. 2012; 1(3): 60-72.
Kunte S, Tandale P. Fast dissolving strips: A novel approach for the delivery of Verapamil. J Pharm Bioallied Sci. 2010; 2(4): 325-328.
Kumar GV, Krishna RV, William GJ, Konde A. Formulation and evaluation of buccal films of salbutamol sulphate. Indian J Pharm Sci. 2005; (67): 160–4.
Nagar M, Nagar M, Chopra V. Formulation and evaluation of mouth dissolving film of antipsychotic drug aripiprazole. Der Pharmacia Lettre. 2012; 4 (4): 1221-1227.
Prabhu P, Malli R, Koland M, Vijaynarayana K, D’Souza U, Harish NM, Shastry CS. Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. Int J Pharm Inves. 2011; 1(2): 99–104.
Nafee NA, Boraie MA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003; 53:199–212.
Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast dissolving film of salbutamol sulphate. Drug Dev Ind Pharm. 2005; 31: 25–34.
Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Hirano K, Yamamoto M, Kinosada Y, Itoh Y. Preparation of a fast dissolving oral thin film containing dexamethasone: A possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm. 2009; 73(3): 361-365.
Published
Abstract Display: 780 
PDF Downloads: 876 
